Assessing the Lifetime Economic Burden in Younger, Midlife, and Older Women with Metastatic Breast Cancer
Project Title
Assessing the Lifetime Economic Burden in Younger, Midlife, and Older Women with Metastatic Breast Cancer
Funding Dates
9/2017-9/2019
Description
The economic cost data produced by this study will help decision-makers allocate scarce public health resources more effectively for the prevention and treatment of metastatic breast cancer (mBC). For example, the cost projections can highlight cost drivers for women with mBC and motivate population-level prevention, early detection, and timely treatment activities. This study is also identifying cost-effective treatment pathways to improve the quantity and quality of life among women of all ages with mBC to ensure that women with mBC receive high-quality care while minimizing the economic impact on patients and payers. In addition, findings can be used to support value-based pathway driven treatment decisions and inform policymaking.
Research AreasÂ
Principal Investigator
Stephanie Wheeler, PhD, MPH and Justin Trogdon, PhD
Funding
Centers for Disease Control and Prevention
News
- Study estimates costs of treating and living with metastatic breast cancer will more than double between 2015 and 2030, due to increase in cases among younger women
- Study finds excess medical costs associated with metastatic breast cancer, especially among younger women
- University of North Carolina Investigators Awarded New CDC Funding to Study the Economic Burden of Metastatic Breast Cancer